Related references
Note: Only part of the references are listed.Drug resistant Tuberculosis: A review
Jessy Lallungawi Khawbung et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2021)
Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
Pierre Santucci et al.
NATURE COMMUNICATIONS (2021)
The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles
Rajkumar Reddyrajula et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies
Nayera W. Hassan et al.
BIOORGANIC CHEMISTRY (2020)
Synthesis of pyrazinamide analogues and their antitubercular bioactivity
First A. Wati et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide
Wanliang Shi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
Saumu Pazia Juma et al.
BMC INFECTIOUS DISEASES (2019)
Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance
Muhammad Tahir Khan et al.
SCIENTIFIC REPORTS (2019)
Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy
Julie Laborde et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Synthesis, spectroscopic analyses, chemical reactivity and molecular docking study and anti-tubercular activity of pyrazine and condensed oxadiazole derivatives
Abdul-Malek S. Al-Tamimi et al.
JOURNAL OF MOLECULAR STRUCTURE (2018)
Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold
Jan Zitko et al.
MEDCHEMCOMM (2018)
Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance
Muhammad Tahir Khan et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Isoniazid derivatives and their anti-tubercular activity
Yuan-Qiang Hu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis
Shiyang Zhou et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors
Ghada Bouz et al.
MOLECULES (2017)
Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation
Ondrej Jandourek et al.
MOLECULES (2017)
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
Thomas J. Scriba et al.
PLOS PATHOGENS (2017)
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase CIpC1
Pooja Gopal et al.
ACS INFECTIOUS DISEASES (2017)
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA
Nicholas A. Dillon et al.
SCIENTIFIC REPORTS (2017)
Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis
T. S. Chitre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Rein M. G. J. Houben et al.
PLOS MEDICINE (2016)
Tuberculosis Infection and Latent Tuberculosis
Seung Heon Lee
TUBERCULOSIS AND RESPIRATORY DISEASES (2016)
Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis
Nicholas D. Peterson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides
Jan Zitko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Kwonjune J. Seung et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup
Kimberly M. Shea et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Pantothenate and Pantetheine Antagonize the Antitubercular Activity of Pyrazinamide
Nicholas A. Dillon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Alkylamino derivatives of pyrazinamide: Synthesis and antimycobacterial evaluation
Barbora Servusova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation
Deepak Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biochemical Characterization of Quinolinic Acid Phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and Inhibition of Its Activity by Pyrazinamide
Hyun Kim et al.
PLOS ONE (2014)
Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles
Jan Zitko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses
Kwok Chiu Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors
Bini Mathew et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides
Jan Zitko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
New Regimens for Reducing the Duration of Treatment of Drug-Susceptible Pulmonary Tuberculosis
Marcus B. Conde et al.
DRUG DEVELOPMENT RESEARCH (2011)
Current Concepts in the Management of Tuberculosis
Irene G. Sia et al.
MAYO CLINIC PROCEEDINGS (2011)
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Wanliang Shi et al.
SCIENCE (2011)
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis
Kerryn Matthews et al.
TUBERCULOSIS (2011)
Synthesis and antimycobacterial activity of N '-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives
Fatima M. F. Vergara et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Mycobacterium tuberculosis: drug resistance and future perspectives
Giovanna Riccardi et al.
FUTURE MICROBIOLOGY (2009)
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Clifton E. Barry et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides
Martin Dolezal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
A new modification of anti-tubercular active molecules
Ales Imramovsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis of pyrazinamide Mannich bases and its antitubercular properties
D Sriram et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Substituted pyrazinecarboxamides: Synthesis and biological evaluation
Martin Dolezal et al.
MOLECULES (2006)
Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis
KA Wilkinson et al.
CLINICAL INFECTIOUS DISEASES (2005)
Resazurin microtiter assay plate:: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis
JC Palomino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I
HI Boshoff et al.
JOURNAL OF BACTERIOLOGY (2002)
Share Paper
